• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Health System

Latest News

There was significant variability in test frequency and detection rates among patients with AML and MDS. | Image credit: Saiful52-stock.adobe.com
Gaps in Molecular Testing Rates, Targeted Treatment Persist in MDS, AML

July 11th 2025

There are molecular testing gaps in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) treatment, highlighting the need for improved testing and targeted therapy integration.

Image credit: Canva Illustration | Mary Caffrey
What Will AI in Health Care Look Like in the Future?

July 10th 2025

Image credit: Canva Illustration | Mary Caffrey
Using AI for the Medical Note: Game Changer or a Bridge Too Far?

July 9th 2025

AJMC
Trends in Market Share Among Hospitals Participating in ACOs and Nonparticipants

July 9th 2025

AJMC
Managed Care Reflections: A Q&A With David J. Shulkin, MD

July 7th 2025

More News

© 2025 MJH Life Sciences
AJMC®
All rights reserved.